Khairy added that the Special Committee on Covid-19 Vaccine Supply Access Guarantee is looking into other vaccine candidates that are in phase three clinical trials.
What the expert here to view on SOLUTION in regards to this news ? --> Solution Group Says NPRA Approved Facility Design Plan & Layout Of Vaccine Facility
SOLUTN 1.770 +0.12 (+7.3%) OTHERS SOLUTION GROUP BERHAD ("SGB" or "THE COMPANY") APPROVAL OF FACILITY DESIGN PLAN AND LAYOUT BY NATIONAL PHARMACEUTICAL REGULATORY AGENCY, MINISTRY OF HEALTH ("NPRA") SOLUTION GROUP BERHAD
Type Announcement Subject OTHERS Description SOLUTION GROUP BERHAD ("SGB" or "THE COMPANY") APPROVAL OF FACILITY DESIGN PLAN AND LAYOUT BY NATIONAL PHARMACEUTICAL REGULATORY AGENCY, MINISTRY OF HEALTH ("NPRA") Reference is made to the announcement dated 25 November 2020 where it was stated that the Company had on 13 October 2020 submitted the facility design plan and layout of the vaccine fill and finish facility to NPRA for approval.
The Board of Director of SGB wishes to announce that NPRA had vide its letter dated 14 December 2020 (which was received on 17 December 2020) approved the said facility design plan and layout.
The Company will commence the establishment of the fill and finish facility after the receipt of the approval from shareholders of SGB on the proposed diversification of the existing business of SGB and its subsidiaries to include the pharmaceutical related business, at an extraordinary general meeting to be convened.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
daijiao
213 posts
Posted by daijiao > 2020-12-17 09:49 | Report Abuse
Where is paktua?